메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting

HIGHLIGHTS Following an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review Committee (SRC) confirms the trial will continue with no modifications to the protocol. Patient population With the SECuRE trial continuing to recruit, a total of nine participants who had evaluable data by the 25th of November 2025 were included in the interim assessment by the SRC, with the majority of participants receiving at least two cycles of 8 GBq of 67Cu-SAR-bisPSMA each by the data cut-off date. Seven participants received
- 김갑성 기자
- 2026-01-15 22:02
Recognition beyond borders: the life-long commitment of "Grandpa Sugar Pill"

BEIJING, Jan. 15, 2026 -- A news report from China.org.cn on Gu Fangzhou, the father of sugar pills — a live oral polio vaccine: Small, sweet, and slightly gritty when dissolved on the tongue — in the childhood memory of many Chinese lies such a tiny "sugar pill." But it was never just a piece of candy. The story dates back to 1955, when a large-scale outbreak of polio (also known as infantile paralysis) swept across China. Highly contagious and debilitating, the disease mostly struck children aged seven and under. Of the 1,680 specifically reported
- 김갑성 기자
- 2026-01-15 22:00
하트스트림, 독립 응급 의료 기업으로 출범

필립스 응급의료 사업부에 속했던 하트스트림, 이머전시 케어 홀딩스의 첫 플랫폼 기업으로 출범하며, 생명을 구해온 100년의 사명 계승 보셀, 워싱턴주, 2026년 1월 15일 -- 브리지필드 캐피털(Bridgefield Capital)이 응급 의료 제품 분야의 선도기업들을 통합•성장시키기 위해 설립한 플랫폼 이머전시 케어 홀딩스(Emergency Care Holdings, 이하 'ECH')가 14일 인명 구조 응급 의료 기술 발전에 앞장설 새로운 독립 기업 하트스트림(Heartstream)의 출범을 발표했다. 하트스트림은 ECH가 로열 필립스(NYSE: PHG, AEX: PHIA)로부터 필립스 응급의료 사업부(Philips Emergency Care) 인수 절차를 완료함으로써 설립됐다. 이번 거래로 ECH는 공식 출범하게 됨과 동시에 응급 의료 분야에만 전적으로 투자하겠다는 장기 전략을 확립했다. 라이언 랜던(Ryan Landon) 하트스트림 CEO는 이렇게 말했다. "하트스트림은 심정지 생존율을 유의미하게 높이고, 응급 의료 환경에서 임상 결과를 개선하고, 의료 시스템 비용을 절감하고, 의료
- 김갑성 기자
- 2026-01-15 18:44
Aphranel Convenes Cadaver Dissection Class in Thailand Successfully

BANGKOK, Jan. 14, 2026 -- The inaugural "Moyom Biotech • Aphranel Global Expert Advisory Panel • Thailand Anatomy Exchange Conference" was successfully convened in Thailand. This high-level forum gathered leading experts from multiple Asia-Pacific countries. Through this concentrated academic dialogue, Aphranel reaffirmed to the industry a clear guiding principle: to return aesthetic medicine to its medical foundation and to safeguard the safe application of regenerative materials through meticulous anatomical science. Dialogue Between Chinese and International Experts
- 김갑성 기자
- 2026-01-15 17:51
Ericsson announces proposed headcount reduction in Sweden

STOCKHOLM, Jan. 15, 2026 -- Ericsson (NASDAQ: ERIC) today announces proposed staff reductions in Sweden as part of measures aimed at ensuring the Company's competitive position. The proposed staff reduction is part of global initiatives to improve cost position while maintaining investments critical to Ericsson's technology leadership and the execution of the strategy to deliver high-performing, programmable networks that enable differentiated services and new monetization opportunities. Initiatives to increase operational efficiency will continue across the Group but will not b
- 김갑성 기자
- 2026-01-15 17:04
MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026

Medical AI Made Easy—From Lab to Real-World Training & Practical Use CHEROKEE, Texas, Jan. 15, 2026 -- MediCapture Inc., a global leader in medical imaging systems, today announced the launch of aiScope™, software that runs Vision AI models in real-time, locally on MediCapture's MTRs and selected MVR imaging systems. First aiScope™ pilot deployment will be in veterinary science. The technology will be demonstrated live at VMX 2026 in Orlando, Florida, working on MediCapture's VUEES™ University Edition and on portable VUEES™ Mobility platforms. (abbreviated as Veteri
- 김갑성 기자
- 2026-01-15 17:00
AMPLIFON IS A GLOBAL TOP EMPLOYER 2026

Only 17 companies worldwide have earned this recognition for their human resources management practices in 2026. Certification obtained for the first time in the Asia-Pacific region, together with confirmation in Europe, North America, and Latin America. Switzerland, India, China, and Singapore were also certified for the first time MILAN, Jan. 15, 2026 -- Amplifon, the global leader in hearing care services and solutions, is one of 17 companies worldwide certified as a Global Top Employer in 2026, as well as the only company in the hearing care sector to obtain this internatio
- 김갑성 기자
- 2026-01-15 16:30
XA Africa Rebrands to A54, Signaling a New Era for African Tech Investment

[ 메디채널 김갑성 기자 ] The rebranding signals a sharper focus on the African continent for this exclusive angel investor network SINGAPORE, Jan. 15, 2026 -- XA Africa, the exclusive operator-led investment network founded by global technology veterans, today announced its official launch as A54. The rebrand marks a significant milestone in the network's evolution, reflecting its deepened commitment to the 54 nations of the African continent and its growing impact as a primary bridge between global expertise and local innovation. Just over one year since its public launch as XA Africa
- 김갑성 기자
- 2026-01-15 16:00
GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

YONGIN, South Korea, Jan. 15, 2026 -- GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on the sidelines of the 44th Annual J.P. Morgan Healthcare Conference 2026 in San Francisco, USA, to expand their collaboration and strengthen their position in the global clinical trial market. With the rising proportion of multinational clinical trials, sponsors face varying regulatory requirements, clinical environments, and data d
- 김갑성 기자
- 2026-01-15 15:31
Docquity Launches Engage™, an AI and Insights-Powered HCP Intelligence Engine for the Life Sciences Industry

SINGAPORE, Jan. 15, 2026 -- Docquity, a leading health tech company in Asia, today announced the launch of Docquity Engage™, an AI and Insights-powered market intelligence engine designed to help life sciences companies better understand and optimize engagements with healthcare professional (HCP) audiences. Backed by real-world insights from Docquity's network of more than 500,000 verified doctors across Asia, Docquity Engage™ provides pharmaceutical brand and field teams with real-time visibility into HCP behaviors and preferences, supported by AI-assisted recommendations to enable mo
- 김갑성 기자
- 2026-01-15 13:00

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-01-15_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 15일 23시 40분